Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET

NCT07366710 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Glucose Metabolism
NAFLD (Nonalcoholic Fatty Liver Disease)

Interventions

DRUG: 18F-FDG (oral)
DRUG: 18F-FDG (intravenous)
DRUG: 18F-FET (oral)
DRUG: 18F-FET (intravenous)
DRUG: Glucagon
DRUG: Somatostatin
DRUG: Sodium chloride (placebo)
OTHER: Oral Glucose Tolerance Test

Sponsor

Rigshospitalet, Denmark